(Total Views: 104)
Posted On: 01/27/2017 11:51:13 AM
Post# of 46523
$IMLFF InMed’s proprietary in silico drug/disease bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the Company.
https://www.inmedpharma.com/about-us/overview/
$VBIO $GWPH, $AXIM
https://www.inmedpharma.com/about-us/overview/
$VBIO $GWPH, $AXIM
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼
